Effective for dates of service on and after October 1, 2022, updated step criteria for immunoglobulins found in Clinical Criteria document ING-CC-0003 has been implemented. The preferred product list is being expanded. Please refer to the Clinical Criteria page for more information.

 

NYBCBS-CR-003772-22-CPN3658



Featured In:
October 2022 Newsletter